Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
ShotTracker scores partnership with sports equipment giant Spalding
Overland Park, Kan.-based startup ShotTracker will partner with Spalding, the largest basketball equipment supplier in the world, to debut the first multi-player basketball tracking technology. ShotTracker’s technology tracks real-time basketball performance statistics using data from chips embedded in a basketball, players’ shoes, and portable sensors placed around the court. Davyeon Ross, COO of ShotTracker, commented that their…
After waning state support, Kansas Bioscience Authority will go private
A formerly state-backed investment organization for Kansas bioscience businesses will soon be transitioning from a public to private organization. After dwindling support from the State of Kansas, the Kansas Bioscience Authority’s board recently voted unanimously to shift the organization to the private market in 2016, allowing portfolio companies to partner with investors in the private…
Rightfully Sewn founder stitches a vision for Kansas City’s fashion future
Poised, posh and purposeful, Jennifer Lapka Pfeifer sits straight as a board at Kaldi’s coffee shop with unwavering eye contact. Donning a contoured-floral blue and white dress, Lapka smiles as she poetically recalls painting in high school and learning to sew with her grandmother in rural Kansas. Those experiences fostered a love for fashion, art…
By the Numbers: A look at Midwest tech investment in 2015
Startland News recently distilled a report by Lead Bank and investment research firm CB Insights that analyzed the Midwest tech investing scene. Here are a few more of the findings from the nearly 40-page report, as presented by Startland’s Kat Hungerford.